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     PART-1 
 
    INTRODUCTION: 
Corneal blindness is a major public health problem 1and among which 
infectious keratitis is one of the predominant causes of corneal blindness in our 
country. About 100 fungal species representing a wide spectrum including 
yeasts, filamentous fungi and dimorphic organisms have been reported as 
corneal pathogens. Fungal keratitis , one of the common causes of ophthalmic 
mycoses if left untreated can lead to corneal scarring and blindness. Fungal 
keratitis constitutes one of the most challenging forms of microbial keratitis for 
the ophthalmologist to diagnose and treat successfully as it is difficult in 
making the correct diagnosis, to obtain topical antifungal preparations, also they 
do not work as effectively as antibiotics for bacterial infections, and the 
infection is often in more advanced stage because of delays in making the 
correct diagnosis3. There may be therefore limited success in treatment. The 
main limitations of antifungal treatment include narrow antifungal spectrum of 
activity, poor tissue penetration, significant side effects or fungal resistance. To 
overcome these problems alternative routes such as intracameral & intrastromal 
routes are being evaluated. Intervention with intrastromal voriconazole has been 
found to be effective in cases of fungal ulcers not responding to topical 
antifungals in this study. 
 
                                                     
REVIEW OF LITERATURE: 
The cornea is a transparent avascular watch glass like structure comprising the 
anterior one sixth of the outer coat of the eyeball 
FUNCTIONS OF CORNEA: 
Cornea is a highly specialized structure which refracts and transmits light which is 
necessary for ideal visual function. It subserves the following functions: 
 Forms a protective interface with the environment 
 Refracts light. 70% of the total refractive power is contributed by the 
cornea. 
 Contains the intraocular pressure1 
ANATOMY OF CORNEA: 
The anterior surface of the cornea is elliptical while the posterior surface is circular 
with the former having average horizontal diameter of 11.75 mm, vertical diameter 
of 11 mm and the latter’s average diameter being 11 mm.8 Cornea is approximately 
1- mm thick peripherally and 0.5 mm thick centrally.5 
It comprises of five layers: epithelium, bowmans layer, stroma, descemets 
membrane and endothelium. Recently in 2013 harminder singh dua et al suggested 
the existence of another layer called Dua’s layer between the stroma and the 
descemets membrane.1 
 
                                            
 1.EPITHELIUM:The stratified squamous epithelium has about five to seven 
layers is around 50 microns thick. It has three to four outer flat squamous cells, one 
to three middle layer of epithelial cells called wing cells as they have lateral wing 
like extensions and single basal layer of columnar cells.4 The complete turnover of 
the epithelium takes place in approximately five to seven days. Keratins constitute 
the major protein of the corneal epithelium. The basal cells of the epithelium 
adheres to the basement membrane and underlying stroma through adhesion 
molecules.  
2.Bowman’s layer is an acellular layer composed of proteoglycans and collagen 
fibrils. It shows greater resistance to both injuries and infections. It does not 
regenerate once destroyed. 
3.The stromal layer is approximately 500 micron thick and forms about 90% of the 
cornea. It is secreted and maintained by the stromal fibroblasts termed keratocytes. 
Birk and Trelstad demonstrated that stromal surface compartments with bundles of 
parallel collagen fibrils are present in fibroblasts.  
                                           
4.Descemet’s membrane is the basement membrane of the corneal endothelium 
and is synthesized by the latter. At birth it is approximately 3 microns wide but by 
late adulthood it can increase upto 12 microns. It can regenerate when destroyed.in 
the periphery it ends as schwalbe’s line at the anterior limit of the trabecular 
meshwork.on electron microscopy it has vertically banded anterior one third region 
and granular amorphous posterior two third region. 2 
5. The corneal endothelium is a single layered low cuboidal epithelium. There are 
large numbers of mitochondria within the cytoplasm of endothelial cells. It does 
not regenerate unlike the epithelium. It is metabolically active. In the basolateral 
border of the endothelial cells Na-K-activated adenosine triphosphatase pump is 
present which plays a major role in maintaining stromal hydration. The endothelial 
cells are attached by desmosomes to the descemets membrane and laterally to each 
other by tight junctional complexes. 
BLOOD SUPPLY: Cornea is an avascular structure. It derives its nourishment 
from small loops in the sub conjunctival space derived from the anterior ciliary 
vessels which invade its periphery . however corneal vascularisation can occur in 
various disease processes the purpose of which is to facilitate transport of systemic 
antibiotics and nutrition. Maurice et al demonstrated that both mechanical- 
structural loosening of stroma by edema and chemical- vasostimulatory factor are 
essential for neovascularisation to occur. 6 
CORNEAL INNERVATION: The corneal epithelium is the most highly 
innervated of all epithelia. the sub basal plexus forms a dense meshwork over a 
large central area. Muller et al studied that there are about 6000 nerve bundles in 
the sub basal corneal plexus  comprising of unmyelinated straight and beaded 
nerve fibre bundles each of which gives rise to seven axons resulting in 19000 to 
44000 axons. 6 These give off about twenty nerve terminals which are extrapolated 
to result in around 7000 nociceptors/mm2 therby making cornea as the most highly 
innervated structure in the body. There are however no nerves in the central 
posterior part of the cornea, descemets membrane and the endothelium. The 
existence of these nerves is crucial for the health of the corneal tissue. Within a day 
of corneal nerve impairment epithelial cells lose their microvilli by swelling up and 
slough off at an accelerated rate. Therefore the epithelium loses its ability to heal 
after injury and even if healed the new tissue will be at a higher risk of 
spontaneous breakdown after corneal denervation. 
APPLIED PHYSIOLOGY OF CORNEA: 
Its two primary physiological functions are that it acts as a powerful refractive 
medium and it protects the intraocular contents. 
The factors contributing to corneal transparency include anatomical factors such as 
avascularity,  absence of myelination in nerves, uniform and regular arrangement 
of corneal epithelium and the  peculiar arrangement of corneal lamellae and 
physiological factors i.e cornea being in a relative state of dehydration. 
Maurice proposed the lattice theory which states that: the corneal transparency is 
maintained as the stromal collagen fibrils are equidistant from each other and are 
of equal diameter( 275-350 A). this arrangement causes the cancellation of 
scattering of incident ray by each collagen fibril by the interference of other 
scattered ray.3 
The factors affecting the corneal hydration include: the corneal epithelial and 
endothelial barrier, intraocular pressure and the metabolic pump function. 
Compromise of either of these barriers results in corneal swelling much of which 
occurs when corneal endothelial cells are compromised. 
The normal corneal stromal swelling pressure is 60 mm Hg. If the endothelial 
barrier is disrupted the intraocular pressure of 15 mm Hg is unopposed and thereby 
aqueous seeps into corneal stroma leading to stromal swelling. 
The optical function is contributed by both the anterior and the posterior surfaces. 
The refractive power at the air-tear interface is about +44 dioptres, +5 dioptres at 
the tear-cornea interface and -6 dioptres at cornea-aqueous interface. 
 
 
 
REGENERATION/ HEALING MECHANISM IN CORNEA: 
A.Epithelial healing: 
The superficial epithelial cells are constantly shed into the tear pool and the 
epithelium renews itself within approximately 5 to 7 days. Unipotent stem cells 
which are located in the basal epithelium of corneoscleral limbus is thought to be 
responsible for the maintenance of the corneal epithelium. Wiley and associates 
used immunohistochemical staining for antibodies to keratins 7and found that 
regional heterogeneity exists and that the limbus and superior corneal periphery 
contain the maximum number of stem cells producing replacement epithelial cells. 
b. stroma: the response to any injury involves the following phases: 
-removal of damaged tissue: the primary response will be the keratocytes death 
adjacent to the wound site which can last long upto one week followed by an 
inflammatory response 
- proliferative and migratory phase: the nucleoli increase in number and size. 
Remodeling of the cytoskeleton takes place and the keratocytes get transformed 
into fibroblasts. 
-phase of repair and replacement:  the fibroblasts proliferate after the repair cells 
migrate into the acellular zone. Contraction of the myofibroblasts is associated 
with scar formation. 
-termination of the wound healing process: within three to six Days post injury cell 
numbers return to normal. 
-endothelium: cell migration and the enlargement rather than proliferation  
contributes mainly to the corneal endothelial wound healing. Thus the injury 
results in both pleomorphism and polymegathism( i.e cells with abnormal shape 
and size.) 
DRUG PERMEABILITY ACROSS THE CORNEA: Topical route in the form 
of eye drops is commonly used as it has the advantages of : the drug effect 
localized to the area where it is needed , avoids hepatic metabolism, is easy and 
convenient, minimal systemic absorption. The following factors affect the drug 
penetration through the layers of cornea 8: 
1.water and lipid solubility of the drug: 
 Hydrophilic compounds have more resistance to absorption from the corneal 
epithelium while the lipophilic drugs encounter resistance in infiltrating the 
stromal layers.Lipophilic compounds are preferred more for corneal absorption as 
epithelium is the first and the main barrier for the drug absorption into the eye. 
2.concentration, molecular size and weight of the drug 
3.ionic form of the drug: ionized forms can pass through the stroma while non 
ionized forms can pass through the epithelium. 
4. Ph of the solution 
5. tonicity of the solution 
6.surface active agents 
 
 
NORMAL DEFENSE MECHANISM AGAINST CORNEAL INFECTIONS: 
Cornea acts as a major defense mechanism against microbial infections. The 
corneal epithelium acts as a mechanical barrier while the pre-corneal tear film’s 
components act as a major biologic protective system.the anatomical barriers to 
corneal infection the bony orbital rim, eyelids, intact conjunctival and corneal 
epithelial surface 3. The mechanical barriers include blinking mechanism,tear film 
and punctual drainage system.  
 
 
  
 
CORNEAL ULCER: corneal inflammation associated with significant loss of 
epithelium is called corneal ulcer. Microbial keratitis is the commonest causative 
factor of corneal ulceration which is important because of its sight threatening 
nature. 
 
AETIOPATHOGENETIC CLASSIFICATION OF MICROBIAL 
KERATITIS: 
a.bacterial- gram positive 
                   gram negative 
b.fungi- filamentous, yeast 
c. parasitic-protozoa 
d.viral keratitis 
 
 STAGES OF CORNEAL ULCER: 
 
 
1.PROGRESSIVE STAGE:  
Adhesion of microbes to the corneal epithelium and release of toxins and enzymes 
causing tissue destruction. 
Saucer shaped ulcer associated with grey zone of infiltration 
Projecting walls of the ulcer 
 
2.REGRESSIVE STAGE: 
Host’s defense mechanisms and the antimicrobial treatment is responsible for this 
stage 
Symptomatic improvement noted along with decrease in signs 
Margins and floor of the ulcer become smooth with line of demarcation noted. 
Superficial vascularisation too noted. 
3.HEALING STAGE: 
Epithelisation begins and scar tissue is formed as keratocytes are converted to 
fibroblasts. 
Vascularisation at the ulcer site results in influx of antibodies and fibroblasts 
thereby promoting healing. 
After complete healing vessels regress and become ghost vessels. 
Kenyon et al: inflammatory mechanisms in corneal ulceration reported different 
stages of ulcer. 4 
 
 
  
FUNGAL INFECTIONS OF EYE: 
Fungi can infect almost any structure of the eye including cornea, conjunctiva, 
uveal tract, lens, ciliary body and vitreous. Predisposing risk factors include 
trauma, contact lenses, topical steroids and immunocompromised state.Two main 
factors that has lead to increase in the incidence of fungal corneal infections 
include an altered symbiotic relationship between the bacteria and fungi due to 
antibiotic usage, and due to decreased resistance of tissues due to topical steroid 
usage which makes the normally saprophytic fungi to become facultative 
pathogens. 
FUNGI are commonly opportunistic invaders in compromised corneas as well as 
after trauma with plant or vegetable matter. Fungi have characteristic properties 
like their ability to survive at low redox potential of tissue, grow at body 
temperature and neutralize the host defense mechanisms. 
In 1857, Virchow coined the term mycosis. It was then the first description of 
fungal keratitis being made. In 1879, Leber first reported Aspergillus as the 
etiological agent for a case of corneal ulcer with hypopyon.In 1913,cavara reported 
Mucor as causing keratitis.Romano yalour et al described candida albicans causing 
typical clinical picture of corneal ulcer with hypopyon.In 1951, s.fazakas first 
found Cryptococcus to cause deep and extensive corneal involvement leaving little 
opacity 
 
EPIDEMIOLOGY 
INCIDENCE and GEOGRAPHIC DISTRIBUTION:It is greater in developing 
countries.its an important cause of morbidity and blindness in tropical countries 
and is attributed to the fact that the main working population in these countries are 
engaged in the agricultural industry where they are exposed to injury with 
vegetable matter. 
Srinivasan et al (2004) reported fungal keratitis as enormous public health problem 
in south india with fungi accounting for 44% of corneal ulcers among which 
fusarium accounted for 47% and aspergillus 16%. 37 
Review of Indian literature reveals that the common fungal species causing fungal 
keratitis are aspergillus and fusarium .5  
Fungal keratitis is more common in rural areas and warm climates. Of late fungal 
keratitis is increased in incidence due to the following factors: 
a) Indiscriminate use of antibiotic-steroids and immunosuppressants 
b) Greater incidence of clinical features recognition 
c) Improved lab techniques. 
d) Better reporting 
 
SEX DISTRIBUTION: it tends to occur more commonly in males than females.1 
Thomas PA: Fungal infections of the cornea2 
AGE DISTRIBUTION: it is common in the age group 21-50 years.2 
SEASONAL VARIATION:a higher incidence of these infections occur during 
early winter,And  monsoons because of the high humidity  and during the harvest 
season because of greater incidence of vegetative injuries during that period. 
Hagan et al: causes of suppurative keratitis in Ghana- studied that the incidence is 
common in tropical climates 
Coster DJ et al in 1981 demonstrated that the incidence of fungal keratitis remains 
very low in temperate climates. 
RISK FACTORS IN THE DEVELOPMENT OF FUNGAL KERATITIS: 
Wilson et al and Choudhry et al studied different agents of oculomycosis7 
Ocular factors include 
• Trauma :trauma is the most common risk factor for these infections. 
Keratomycosis in children is usually associated with trauma with 
vegetative matter. higher incidence of filamenous fungi being isolated 
after trauma with vegetable matter as these are implanted directly by the 
injuring material. These usually infect normal eyes of healthy young 
individuals who have mild corneal trauma with vegetable matter. this is 
frequently noticed in farmers and outdoor labourers 6 
• ocular surface problems including dry eye, bullous keratopathy, 
exposure keratitis,  
•
 contact lens wear: 3-12% of infections are associated with contact lenses. 
Yeasts are commonly associated with bandage contact lenses while 
filamentous fungi commonly with aphakic or cosmetic contact lenses. 
Predisposing factors to contact lens related infection include improper 
lens care and topical steroids in patients with chronic epithelial defect 
among therapeutic lens wearers. 11 
• Drug abuse mainly corticosteroids and anaesthetics8 .corticosteroids 
suppress ocular immune mechanisms by inhibiting chemotaxis and 
ingestion by phagocytes. They also decrease the production of 
phagocytes and block degranulation too. In 1953, Thygeson and his 
colleagues were the first to suggest the role of corticosteroid usage in the 
development of fungal infections.In 1959, Anderson et al proposed the 
role of suppression of bacterial growth by antibiotics in the proliferation 
of fungi. In 1956, ley ; in 1964 van winkle et al : fungal corneal reaction 
is less severe when penicillin is used therapeutically in cases of mixed 
corneal ulcers where as ulceration tends to be more severe when 
antibiotics are added in absence of secondary infection . 
•
 post any ocular surgery including cataract surgery, keratoplasty and 
refractive surgery. Predisposing factors are loose sutures, contact lens 
wear,  chronic antibiotic- steroid usage, graft failure and persistent 
epithelial defects for the development of fungal keratitis in patients post 
keratoplasty.14 
Following  refractive surgery fungal keratitis can occur either in the early 
period due to direct surgical contamination or in the late period  due to trauma. 
• The systemic factors include immunocompromised state, diabetes 
mellitus, patients with chronically debilitated diseases. HIV positive 
patients are more likely to develop bilateral fungal keratitis compared to 
non –HIV positive patients. Candida and yeasts are more frequently 
opportunistic than filamentous fungi. 
 
  
 
GENERAL MYCOLOGY: 
Fungi are complex eukaryotic organisms having a nucleus, membrane bound 
granules, a rigid cell wall containing polysaccharides, chitin and ergosterol. fungal 
cells are larger than bacteria. Fungal virulence factors include capsule production 
to inhibit phagocytosis , cytokines production to depress immune system, cell wall 
polysaccharides that activate complement cascade inciting an inflammatory 
reaction or secretion of cytokines and mycotoxins that directly damage the host 
tissues.  
 
 
 
 
 
 
  
MORPHOLOGICAL CLASSIFICATION OF FUNGI 
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YEASTS: these are unicellular organisms characterized by a round 
blastoconidium. They reproduce asexually by budding. In budding the nucleus 
will undergo mitosis and a daughter cell pinches off to produce a new cell 
containing the new nucleus.These are characterized by pseudohyphae which 
form under reduced oxygen tension in the tissue .This pseudohyphal phase 
constitutes the most virulent phase. 7 
YEASTS LIKE FUNGI: these organisms grow partly as yeast and partly as 
elongated cells resembling hyphae which forms pseudomycelium. 
FILAMENTOUS FUNGI/MOULDS: these are multicellular organisms which 
possess hyphae and grow by either branching or apical extension. Hyphae are 
rigid tubes containing cytoplasm that moves towards the growing tip 
continuously to supply it with materials for growth.They reproduce either 
asexually by spore formation or sexually. They can be classified as septate or 
non septate based on the presence or absence of cross walls in the hyphae. 
                         
 The septae have pores through which cytoplasm and nuclei pass to reach the 
growing tip. Septate hyphae possessing fungi cause most cases of fungal 
keratitis. Predominantly etiological agents are non pigmented fungi like 
fusarium species, aspergillus, penicillium and acremonium. Pigmented fungi 
include alternaria, bipolaris, curvularia, phialophora and lasiodiplodia. 
DIMORPHIC FUNGI: these can occur as yeast or as filaments based on the 
growing conditions. They occur as yeasts at 37 degees C and at 22 degreesC 
appear as moulds.  These rarely cause keratitis. Blastomyces, histoplasma, 
coccidioides and sporothrix come under this category.    
Fungi reproduce generally by forming spores which may be asexual ( mitosis 
only) or sexual as a result of fusion of two cells followed by meiosis. These 
asexual spores of medically important fungi are called conidia. 

 
MAJOR CLASSES OF FUNGI BASED ON SEXUAL SPORES: 
1.ZYGOMYCETES: These are septate filamentous organisms which are 
rare human corneal pathogens. 
2.ASCOMYCETES: Genera Aspergillus and Penicillium come under this 
class of septate fungi which contain spores in their sacs or asci. 
3.BASIDIOMYCETES: These septate fungi have club shaped structures 
called BASIDIA which has their sexual spores. This class includes 
mushrooms and plant rusts. 
4.DEUTEROMYCETES OR FUNGI IMPERFECTI: This class lacks 
sexual spores and includes most human corneal pathogens. These are 
again further divided into Moniliaceae and Dematiaceae based on the 
colour of hyphae. White or light coloured hyphae containing moulds  are 
called hyaline fungi and come under the Moniliaceae group. Dematiaceae 
group contains moulds with brown or black pigmented walls. this 
pigmentation is because of the melanin contained in the fungal hyphal 
walls.     
 

 
 
MORPHOLOGY OF FUNGI: 
These are saprophytic organisms as they are plant like but lack chlorophyll .fungal 
cell wall is composed of polysaccharides and lipids. 80-90% of fungal cell wall is 
made up of polysaccharides which is usually cellulose or chitin. Unlike the animal 
cell wall containing cholesterol ergosterol is the sterol here.                                                         
FUNGI MORPHOLOGY 
YEAST AND YEAST LIKE(UNICELLULAR FUNGI THAT 
REPRODUCE BY BUDDING)  :  
Macroscopic morphology: these form non mucoid creamy textured smooth 
colonies  
Microscopic morphology: these are round to oval shaped budding cells which 
can produce germ tubes which are parallel sided tubes and are formed at right 
angles to the parent cell. 
 
ASPERGILLUS SPECIES: 
Aspergillus is a large genus with many species out of which A.fumigatus and 
A.niger are particularly important.Their hyphae have dichotomous branching 
which is a diagnostic feature. The conidiospores have swollen terminal vesicles 
surrounded by flask shaped sterigmata each of which produce long chains of 
coccoid conidia radiating out from the vesicle. Three of aspergillus species are 
common corneal pathogens. 
                                         
Aspergillus flavus: 
Macroscopic morphology: colonies are flat,granular often with radial grooves 
yellow to green in colour  
Microscopic morphology: conidial heads are mostly 300-400 micron in 
diameter and typically radiate. Biseriate heads but some with phialides borne 
directly on the vesicle.conidiophores are hyaline and roughened. 
Aspergillus fumigatus: 
Macroscopic morphology: colonies show typical blue green surface 
pigmentation with a suede like surface with dense felt of conidiophores. 
Microscopic morphology: 
Conidial heads are typically columnar, uniseriate. Conidiophores are short, 
smooth walled with conical shaped terminal vesicles . These have one row of 
phialides on upper two thirds of the vesicle. Conidia are green, globose and 
rough walled and are produced in basipetal succession forming long chains. 
Aspergillus niger: 
Macroscopic morphology:colonies are white or yellow in colour covered by a 
dense layer of dark brown to black conidial heads. 
Microscopic morphology: conidial heads are globose large dark brown with 
smooth walled hyaline conidiophores with biseriate conidial heads .the conidia 
are dark brown to black, globose and rough walled. 
2.FUSARIUM: 
Macroscopic morphology: they produce wooly to cottony , flat , spreading 
colonies. 
Microscopic morphology: 
They are characterized by the large banana shaped or sickle shaped conidia 
which are produced on short lateral hyphae-conidiospores. 
3.CANDIDA: 
Macroscopic morphology: these colonies are convex non mucoid cream 
coloured colonies  
Microscopic morphology: They have round oval shaped budding cells. True 
germ tubes are produced which are parallel sided tubes formed at right angles to 
the parent cell when incubated in serum for 2-3 hours at 37 degrees. 
4.DEMATIACEOUS FUNGI:these are generally darkly pigmented because of 
the melanin present in their hyphal walls.this characteristic dark colour is 
generally noticed on potato dextrose agar and often appear salmon coloured on 
saboraud’s dextrose agar. 
In Garg and colleagues study16, only 27% of the dematiaceous fungi caused 
corneal ulcers appeared to be darkly pigmented macroscopically. they studied 
88 cases of keratomycosis caused by dematiaceous fungi in india among which 
50% could not be further identified as they did not sporulate and of the 
remaining half curvularia was the most common species (23%) followed by 
exserohilum and bipolaris( 15% combined) 
-CURVULARIA:  Mostly they are facultative pathogens with curvularia lunata 
being the most commonly encountered species. It has now emerged as an 
opportunistic pathogen infecting immunocompromised patients. 
-ALTERNARIA: Most common fungus isolated in this group. It has also 
emerged as an opportunistic pathogen. 
-AUREOBASIDIUM PULLULANS: It comes under phaeohyphomycoses 
group. These usually cause centrally located ulcers with multiple round ball like 
infiltrates around the ulcer. 
RHIZOPUS: 
Mcroscopic morphology: cotton candy like texture of these rapidly growing 
colonies.front surface of the colony is white initially which turns grey to yellow 
brown later while the reverse surface is pale white. 
Microscopic morphology: these have broad hyphae which may be either non 
septate or sparsely septate.they have brown colour sporangiophores on the tip of 
which round sporangia are located with flattened bases. At the junction of 
stolons and sporangiophores rhizoids are located. 
                                                   
PATHOGENESIS OF FUNGAL CORNEAL ULCER:  
Ocular infection occurs as a result of breach in the normal healthy interaction 
between three important factors- the host, pathogen and the environment. 
The pathogenicity of the fungi is dependent on the characteristics of the 
invading organism and the status of the normal defenses of the host. The 
inflammatory reaction results from: 
• Damage caused by fungal toxins and proteolytic enzymes. 
• Fungal invasion and growth causing direct physical damage. 
• Damage caused by infiltrating leucocytes. 
• Soluble fungal antigens 
Host leukocytes infiltration with ring abscesses composed of plasma cells, PMN 
leukocytes and eosinophils are characteristic of fungal corneal ulcer.( 
zimmermann, naumann G, Green) 
Neutrophils destroy fungal hyphae and damage the surrounding tissue via 
exaggerated phagocytosis thereby releasing oxygen metabolites and lysosomal 
enzymes.(Diamond et al). 
Few studies have investigated the role of fungal enzymes and toxins as 
contributing factors in pathogenesis. Few strains of aspergillus produce aflatoxins 
and ochratoxins whose role in corneal infection is not known.other toxins include 
trichothene toxins produced by fusarium and acremonium species which elicit 
inflammation at low doses and destroy many cell types at higher concentrations. 
Other toxin is the gliotoxin produced by penicillium, aspergillus and gliocladium 
species which are epipolythiodioxopiperazines having antibacterial, antiviral, 
antitumor and anti-phagocytic properties. Canditoxin is produced by canida 
albicans species.it also produces proteolytic enzymes- aspartyl acid protease, 
neutral and carboxyl proteases and phospholipaes. 
The destructive potential varies from the rapidly destructive Fusarium to lesser 
virulent acremonium species. Fungi can penetrate the stroma, attack descemets 
membrane and enter the anterior chamber unlike the bacteria. Multiple virulence 
factors act on the host like the cell wall polysaccharides that provokes 
inflammatory reaction by activating the complement cascade. 
HOST IMMUNITY: 
Host’s cell mediated immunity play an important role in protection against fungal 
infection. Neutrophils contain myeloperoxidase and hydrogen peroxide which 
attributes to its fungicidal property. 
CLINICAL EXAMINATION OF A CASE OF CORNEAL ULCER: 
• general examination  
• visual acuity recording 
• eyelids for the presence of any abnormality like trichiasis, ectropion, 
entropion, lagophthalmos 
• nasolacrimal duct patency 
• slit lamp examination- to look for the size and depth of the ulcer, anterior 
chamber reaction, associated characteristic findings. 
• intraocular pressure. 
• Posterior segment evaluation to be done in cases of suspected 
endophthalmitis. 
CLINICAL PRESENTATION OF FUNGAL KERATITIS: 
In 1965, Kaufman and Wood described the salient features of mycotic keratitis.  
SYMPTOMS: 
• Gradually increasing pain 
• Defective vision:  central corneal ulcers particularly caused by fusarium 
are invariably associated with significant loss of visual acuity. 
• Foreign body sensation 
SIGNS: 
 Circumcorneal injection 
 Early features include granular infiltration upto the anterior stroma with 
minimal cellular reaction. 
 Dry looking ulcer with feathery margins with rough texture and dirty grey 
white colour. 
 Elevated edges 
 Satellite lesions or multifocal suppurative microabscesses. 
 Anterior chamber inflammation, Fixed immobile hypopyon and endothelial 
plaque usually parallels the density and size of the lesion. Hypopyon usually 
results from sterile reaction to fungus and its toxins. But however the fungi 
can invade the anterior chamber through intact descemet’s membrane and 
forms a fixed hypopyon.thus the exudation in the anterior chamber is not 
sterile unlike the bacterial ulcers. 
 A white ring noted representing the interactive junction of fungal antigen 
and host antibody or toxic fungal diffusate. 
 In dematiaceous fungal keratitis pigmentation in the ulcer bed is noted 
occasionally. 
 The entire cornea becomes homogenously white in advanced disease. 
 endothelial plaque:  It is composed of fibrin and leukocytes. It is located 
under the stromal lesion and can be present even when hypopyon is not 
present.  
 
SPECIFIC CHARACTERISTIC FEATURES OF KERATITIS  
1.BY FILAMENTOUS FUNGI: 
 Most often followed by a history of trauma with vegetable matter. 
 Can involve any part of the cornea 
 Ulcer characterized by elevated grayish white infiltrate with hyphate 
margins and surrounding satellite lesions which are discrete stromal 
abscesses separated by clear cornea. 
 Irregular elevated feathery margins and endothelial plaques composed of 
inflammatory cells seen. 
 Hypopyon commonly associated. 
 F.solani keratitis often causes stromal ulceration and necrosis leading to 
perforation and endophthalmitis. Acremonium species causes dense 
suppuration. 
2.BY NON FILAMENTOUS FUNGI: 
 Most commonly seen in eyes with preexisting surface abnormalities, 
yeast keratitis commonly occurs in association with systemic diseases 
such as immunoglobulin A deficiency, cell mediated immunodeficiency. 
 Ulcer site usually at the junction of upper 2/3rd and lower 1/3rd. 
 Usually no feathery margins, no hyphate edges, no satellite lesions. 
 Small oval ulceration with sharply demarcated dense stromal suppuration 
that lacks the typical delicate features of filamentous keratitis. 
 
SEVERITY GRADE OF MICROBIAL KERATITIS: 
Jones gave the following criteria for the severity grading of ulcer based on the 
signs: 
FEATURE NON-SEVERE SEVERE 
Rate of progression Slow, moderate Rapid 
Area of suppuration < 6 mm diameter >6 mm diameter 
Depth Superficial 2/3 rd Inner 1/3 rd 
Depth of ulceration Superficial 1/3 Inner 1/3 
Perforation Unlikely Present, imminent 
Scleral suppuration Absent Present 
 
Depending on the severity ulcers may be graded as follows: 
Factor GRADE 1 GRADE 2 GRADE 3 
LOCATION Non axial Central/peripheral Central/peripheral 
AREA 2 mm 2-6 mm >6 mm 
DEPTH Superficial 1/3rd Superficial 1/3rd-
2/3rd 
Extending to inner 
1/3rd 
anterior segment 
inflammation 
None/mild Moderate to severe 
fibrinous 
infiltrates 
Hypopyon 
 
DIAGNOSIS: 
 Flowchart for diagnosis and isolation of causative organism in infectious 
keratitis: 
 
• History 
• Ophthalmic examination 
• Systemic examination 
 
 
 
 
                                     SMEARS              CULTURES 
Laboratory techniques: there are some guidelines for proper procurement and 
examination of specimens.: 
-gram and giemsa stains are absorbed by the protoplasm of filamentous fungi 
but do not stain the septa of fungal hyphae or the cell wall. 
-oil immersion is not necessary and high magnification alone is sufficient to 
detect fungal organisms. 
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Jones et al: key to positive isolation of the causal organism in fungal infections 
is careful attention to diagnostic techniques and repeated attempts to isolate the 
microorganism in culture. 
The elements are rarely present in corneal smears that allow classification: 
Aspergillus- small hyphae with distinct cross septa and branching at 45 degrees. 
Nocardia- gram positive, acid fast partially with delicate branching filaments. 
Candida- budding characteristically noted in yeast forms 
Yeasts- stain dark blue typically. 
Corneal scraping: Smears are taken from the ulcer margins and bed, lid 
margins and conjunctival sac under topical anaesthesia using bard parker 15 
blade or with platinum loop after obtaining consent from the patient. Care is to 
be taken not to perforate the thinned areas and the direction should be always 
towards one side only.These smears are prepared on pre cleaned glass slides 
and fixed with 5% methanol. These slides are processed for the following stains 
after keeping one slide in reserve16 
i. Grams stain- it stains the fungal protoplasm selectively. Most fungi are 
gram positive. Filamentous fungi have varying staining response while 
yeasts are gram positive. This method is also useful to identify any 
coexixting bacterial infection. 
ii. PAS stain- PAS reagent hydrolyses and oxidizes cell wall 
polysaccharides and stain the hyphae as bright red. 
iii. Giemsa stain- it is also a selective stain like grams stain. It imparts 
purplish blue colour to the corneal fungal pathogen. It highlights the 
cytoplasm and septum 
iv. Grocott gomori methenamine silver stain:  it is the most selective method 
for identifying the fungal elements but is a costlier and cumbersome 
technique. Black staining is noted as reduction of silver occurs by the 
oxidized carbohydrate components of the fungal cell wall.15 
v. Calcofluor white and acridine orange are other stains which are easy to 
perform giving rapid diagnosis but the disadvantage is that it requires 
fluorescent microscope. 
KOH MOUNT: 10%KOH wet mount can be used to detect fungi. KOH 
retains only the fungal filaments by dissolving the cells and debris. 19It 
has got low sensitivity as only 1/3 rd of the fungal keratitis are positive 
by this method. In addition to fungal filaments, acanthamoeba cysts and 
nocardia filaments can also be visualized. 
- When examined with UV light candida and aspergillus exhibit 
autofluorescence. 
- Lectins when conjugated with fluorescein can be seen under the 
fluorescence microscope. These bind to the cell walls of yeast, 
filamentous fungi and atypical mycobacteria.; cysts and trophozoites 
of acanthameba 
CULTURE:  
The isolate is transferred directly to the culure plate by making a row of C-
shaped marks reversing the edge of the spatula with each C, so that the entire 
material on spatula is transferred to the plate. This process is repeated several 
times until several rows of C-shaped streaks have been made on each solid 
plate. Although most fungal isolates will be recovered within 48 hrs of 
inoculation, at least 25% may require incubation as long as 3 weeks before any 
growth is recognized. 
CULTURE MEDIA EMPLOYED FOR FUNGAL RECOVERY: 
 BLOOD AGAR: this media supports the growth of most fungi as well as 
bacteria. Two plates are inoculated, one at body temperature and the other 
one kept at room temperature for fungal growth. 
 SABOURAUD’S DEXTROSE AGAR MEDIUM: sabouraud originally 
described the SDA agar formulation which contains 4% glucose. It contains 
dextrose, peptone, agar along with 50 mg of gentamycin to inhibit bacterial 
growth but it should not contain cycloheximide as it might inhibit some 
saprophytic fungi.14 It is an universal readily available nonselective medium 
for the purpose of primary isolation of fungi.to improve nutritional 
characteristics yeast extract is added. Fungi are transferred to the sporulating 
medium after the primary growth. Sabouraud agar plates are generally 
preferred over the slants because of: 
-colony growth can be observed 
-ease of inoculation 
-dilution of inhibitory substances 
- transfer to secondary media 
The specimens are incubated at room temperature in sabourauds agar and the 
agar is thicker than usual medium. 
 LIQUID BRAIN HEART INFUSION RECOVERY: this liquid media offers 
good recovery of fungi and can be used as an adjunct to solid media. This 
broth contains beef heart infusion and calf brain with dextrose and protease, 
neomycin and gentamycin too are added to enhance fungal groth and to 
control bacterial contamination respectively. 
 LACTOPHENOL COTTON BLUE MOUNTING MEDIA: It contains 
phenol, lactic acid, glycerol, cotton blue and distilled water. It is used to 
identify and evaluate different fungal colony characteristics. 
 
 
ORGANISM EARLY  LATE 
Aspergillus fumigates White Velvety green 
Aspergillus niger White Turns black as sporulation begins 
Fusarium White Acquires buff colour as colony matures 
Acremonium Compact Develops wooly appearance 
 
 OTHER SPECIAL MEDIA: 
These include potato dextrose agar, cornmeal agar and czapek dox agar. 
JONES CRITERIA FOR DIAGNOSIS FROM CULTURE: 
Clinical signs of infection plus bacterial isolation (10 or more colonies )on 
one solid medium and one additional medium or isolation of fungi ( any 
detectable growth) on any two media or one medium in the presence of 
smear being positive. 
The colour, growth rate, surface texture, microscopic appearance and 
pigmentation on the reverse side are the initial identifying features 
microscopically. 
CORNEAL BIOPSY: this gives a better yield than corneal smears for 
recovering fungi. Alexandrakis et al demonstrated from the corneal biopsy 
specimens increased recovery rate in cases of recalcitrant culture negative 
cases. 
ANTERIOR CHAMBER TAP can be used to isolate fungal organisms that 
penetrate intact descemet’s membrane. The hypopyon and endothelial 
plaque can be aspirated under aseptic conditions and submitted for 
laboratory examination. In suspected progressive fungal infection with 
repeated negative culture reports anterior chamber paracentesis can be 
indicated. 
In POST LASIK cases sample collection requires special precaution. Here 
the surface scraping is not indicated for the fear of button holing of the flap. 
It should be performed after lifting of the flap and specimen is to be 
collected from both the undersurface and bed of the flap. In cases of flap 
necrosis amputation or excision of flap has to be done to decrease the load of 
infection. 
 NEWER HORIZONS IN DIAGNOSIS: 
-Polymerase chain reaction: it aids in diagnosing microbial keratitis and 
gives rapid results and also picks up cases even in partially treated cases 20.it 
is typically used in one of the following conditions: 
a. When a patient does not respond appropriately to therapy 
b. When a patient has signs and symptoms that are most likely an 
infection but a definite diagnosis is not arrived . 
c. When a patient’s history and clinical presentation does not coincide. 
d. For diagnosis confirmation. 
The ophthalmic samples for PCR are collected either from corneal 
scrapings , infected corneal button, anterior chamber paracentesis, or a 
vitreous tap. 
-In vivo confocal microscopy for early detection of fungal keratitis.it 
provides observation of microorganisms in vivo without the use of any dyes 
or stains or tissue fixation. It precludes the need for invasive procedures like 
corneal biopsy in cases of deep seated infiltrations and delayed growth in 
culture. Yeasts grow in a plane perpendicular to the corneal stromal lamellae 
and appear as multiple round hyperreflective points while filamentous fungi 
traverse in a plane corresponding to the horizontal stromal lamellae and 
appear as multiple linear branching structures. 
-Non specific fluorescent stains like uvitex 2B and Blankphor- rapidly 
detects fungal filaments in corneal scrapings 
 
 
 OTHER FUNGAL IDENTIFICATION TESTS: 
i. Germ tube production 
ii. Biochemical test 
iii. Immunodiffusion 
iv. Latex agglutination tests 
v. Counter immunoelectrophoresis 
vi. Crossed electrophoresis 
vii. ELISA 
HISTOPATHOLOGY: Two histopathological features considered to be suggestive 
of progressive pathogenicity include:orientation of fungal hyphal elements 
perpendicular to the normal corneal lamella and a tendency for the hyphal elements 
to penetrate intact descemet’s membrane. 
 
DIFFERENTIAL DIAGNOSIS: 
 Bacterial ulcers especially pseudomonas . Yeast keratitis often 
resembles gram positive bacterial keratitis like staphylococcal aureus/ 
streptococcus pneumonia. 
 Acanthamoeba keratitis 
 Viral keratitis: filamentous fungal keratitis often mimics viral keratitis 
 Atypical mycobacterial, nocardia ulcers 
 Infectious crystalline keratopathy 
 
 
 
TREATMENT:  
The objective of therapy is to:  
-to provide symptomatic relief for the patient. 
-to reduce the inflammation. 
-to eliminate the infective organism rapidly. 
-to promote epithelial healing and provide structural damage to the cornea. 
GENERAL CONSIDERATIONS IN TREATMENT: 
Lalitha p et al, 2006- lack of effective antifungal agents responsible for inability 
to treat fungal keratitis despite diagnosis.34 
Most of the antifungal agents act on ergosterol present in the fungal cell wall. 
The difference in the plasma membrane constituents between the fungi and the 
host cell has been capitalized on by the antifungal agents as they selectively 
damage the fungal cells while causing minimal damage to the host cells. 
 
CLASSIFICATION OF ANTIFUNGAL AGENTS: 
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POLYENES: they can be classified as larger and smaller polyenes. Though both 
bind to sterols their subsequent effect on the cell membranes differ due to their 
relative size.the larger polyenes approximate the phospholipids present in the cell 
membrane and forms channels for the passage of potassium chloride and other ions 
leading to electrolyte imbalance and thereby cell death. This lethal effect can be 
blocked by the electrolyte control of the surrounding medium. Smaller polyenes 
accumulate on the membrane and form blisters instead of channels and disrupt the 
phospholipid film. This effect is not reversible by the electrolyte control. 
NATAMYCIN: Smaller polyene antibiotic.  
Mechanism of action: it binds to ergosterol in the cell membranes , increases 
cytoplasmic membrane permeability resulting in leakage of intracellular 
constituents. It is available as 5% suspension.it is the only FDA approved 
topical ophthalmic preparation. 
SPECTRUM OF ACTIVITY: 
It is routinely employed for keratitis caused by filamentous fungi and is usually 
more effective against superficial fungal infections that are not very severe as 
the drug has poor penetration into the deeper structures of the cornea. 
Kalavathy et al did a prospective nonrandomized study comparing the efficacy 
of 5% natamycin with 1% itraconazole drops as monotherapy for fungal 
keratitis and concluded that natamycin is more effective than itraconazole in the 
treatment of Fusarium keratitis but is not that efficacious in the management of 
deep stromal infections. 
1. Aspergillus 
2. Fusarium 
3. Curvularia 
4. Acremonium 
SIDE EFFECTS: it is well tolerated 
1. Follicle formation 
2. Conjunctival hyperemia 
3. Persistent epithelial ulceration 
Prajna et al in 2003 found no statistically significant difference between 5% 
natamycin and 2% econazole in a prospective comparative study among 112 
cases of culture proved fungal keratitis.30 
It is the preferred initial agent for treating filamentous keratits as it has a 
broader spectrum of activity, lacks toxicity and has been established as 
efficacious against various types of superficial corneal pathogens. Lack of 
absorption and tissue toxicity precludes its use particularly. It deposits on the 
cornea upon instillation. 
AMPHOTERICIN B: This is a larger polyene antibiotic derived from strains 
streptomycin nooses. 
MECHANISM OF ACTION: It is fungicidal at high concentration and fungi 
static at lower concentrations. It increases the permeability of cytoplasmic 
membranes by binding to ergosterol present in the cell membranes and 
permitting the leakage of intracellular constituents. 
Spectrum of activity includes: 
1. Candida 
2. Aspergillus 
3. Fusarium and other filamentous fungi 
4. Cryptococcus 
ROUTES EMPLOYED: 
• TOPICAL- 0.15%. The parental formulation is diluted with 
distilled water without bacteriostatic agent to prepare the 
topical formulation. 
• Subconjunctival: 1-2 mgs  
• Intracameral route 
Kaushik et al: three culture proven aspergillus flavus corneal ulver patients who 
did not respond to conventional 5% natamycin, 0.15% amphotericin B or oral 
itraconazole had complete resolution of the ulcer and hypopyon on receiving 
intracameral amphotericin B. 
• Intravitreal routes 
• The CLEAR-Collaborative exchange of antifungal research study was a 
retrospective study which reviewed the efficacy and renal safety in candida 
infected patients treated with lipid complex amphotericin B and concluded 
that lipid complex formulations of amphotericin B are effective and are at 
lesser risk of renal toxicity than conventional amphotericin B. 
SIDE EFFECTS: nephrotoxic. 
Higher doses produce conjunctival necrosis 
1. Allergic reactions 
2. Burning sensation 
3. Follicular conjunctivitis 
4. Punctuate keratitis 
5. Delayed corneal wound healing 
6. Uveitis 
7. Subconjunctival injections as low dose as 0.1 mg can cause transient 
conjunctival nodules and also permanent yellow conjunctival discoloration 
NYSTATIN: 
It also belongs to polyene group of drugs which can be used as a topical suspension 
but it is no longer commonly used as it has only superficial activity in vivo  
AZOLES: These antifungals are non selective and has the ability to inhibit many 
mammalian cytochrome P450 dependant enzymes. Therefore the medications 
metabolized through the P450 pathway have drug interactions with the azole group 
of antifungals. 
Mode of action: 
Fungistatic ( inhibits ergosterol synthesis)at low concentration while 
fungicidal(direct damage to fungal cell wall) at high concentration. At 
concentrations used it shows only fungi static activity 
KETOCONAZOLE: 
It was the first successful broad spectrum oral azole antifungal. It has good 
activity against candida albicans but a moderate coverage of aspergillus 
species. It is available both orally and as topical 1% eye drops. Long term 
oral administration is associated with hepatotoxicity and can result in 
complications like gynaecomastia, alopecia or impotence 
TRIAZOLES: 
ECONAZOLE: it is a broad spectrum antifungal and 2% econazole applied 
topically has been found to be efficacious as 5% natamycin in treating 
fungal keratitis. 
CLOTRIMAZOLE: it has a greater tendency to bind to fatty acids but is 
more toxic and cannot be administered systemically. It is available as a 1% 
topical preparation . Mselle treated twelve patients with proven fungal 
keratitis with clotrimazole but concluded that clotrimazole alone as a single 
agent will not be an ideal choice. 
IMIDAZOLES: 
ITRACONAZOLE: it is a broad spectrum synthetic triazole having less 
toxicity and good oral bioavailability. It can be used as 1% suspension . It is 
contraindicated in patients who have hypersensitivity to the drug or its 
components. 
Agarwal et al did a randomized prospective study and concluded that topical 
itraconazole is effective in treating superficial less severe fungal ulcers but it 
may be less efficacious than natamycin in the treatment of Fusarium 
keratitis. 
FLUCONAZOLE: it is a highly water soluble drug available as 0.3% topical 
preparation which acts primarily against Candida species. Oral and 
intravenous formulations are also available. It is very safe and has good 
corneal penetration . A major limiting factor associated with the use of 
fluconazole is that it has a narrow spectrum of activity. 
VORICONAZOLE: It is a recently developed azole antifungal having broad 
spectrum of activity available as oral and intravenous formulation. 
POSACONAZOLE: It is as active as voriconazole having a broad spectrum 
of activity with added activity against zygomycetes. It is a recently 
introduced drug and studies on its ocular penetration are lacking. It is a safe 
drug used both orally and as topical formulation. 
ADVANTAGES OF TRIAZOLES OVER IMIDAZOLES: 
 Lower toxicity 
 Improved selectivity 
 Increased stability 
 Lower rate at self induced hepatic metabolism 
PYRIMIDINES-FLUCYTOSINE: it interferes with protein synthesis by 
incorporating into the fungal RNA.It is available topically as 1% solution 
and systematically as 150 mg/kg/day. It is effective against Candida and has 
synergistic action when combined with Amphotericin B. It is not effective 
against fusarium or acremonium.capsules are dissolved in distilled water to 
obtain 1 percent topical solution. Oral flucytosine controls deep stromal 
suppuration or endophthalmitis as effective aqueous and CSF levels are 
obtained. Adverse effects include hepatic dysfunction, leucopenia, 
thrombocytopenia and gastrointestinal upset 
ECHINOCANDINS: 
These group of antifungal agents target the fungal cell wall by depleting 
glucan polymers in it by inhibiting glucan synthesis and cause a weak cell 
wall. These are selective in action but the oral bioavailability is poor in this 
group. Durand et al reported case report of two patients with aspergillus and 
fusarium endophthalmitis successfully treated with caspofungin in 
combination with voriconazole. 
Matsumoto et al reported resolution of three candida ulcer patients with 
topical 0.1% micafungin who did not respond initially with topical polyenes 
and azoles. 
TERBINAFINE:It is used as 0.25% eye drops and is effective as 5% 
natamycin against filamentous fungi especially in cases of smaller and 
shallower ulcers. It is active against few types of yeasts too. It is safe but 
requires longer duration of treatment. 
 
 
 
In vitro minimum inhibitory concentrations of common antifungals 
Antifungal agent  Aspergillus    Candida      Fusarium  
Voriconazole              0.5             0.016           2 
Amphotericin B             2                 0.5           2 
Itraconazole                   1             0.256           >16 
Fluconazole                >256              0.5           >256 
Ketoconazole                  4             0.032           >16 
 
OTHER ANTIFUNGAL AGENTS: 
Silver sulfadiazine 
Povidone iodine 5% 
0.2% chlorhexidine glucomate. 
DURATION OF TREATMENT: The length of time required for topical 
treatment has not been firmly established. Different reviews have lead to the 
derivation of certain guidelines. Generally the time taken is longer than that 
for bacterial keratitis. It should be individualized based on clinical response. 
Jones et al reported an average duration of 30 days of treatment for fusarium 
keratitis with natamycin. Penetration of many topical antifungal agents is 
poor which can be aided by repeated scraping off the epithelium. 
 
 
 
SYSTEMIC ANTIFUNGAL AGENTS : 
These are employed in cases of 
 Deep ulcers 
 Very large ulcers 
 Associated scleritis/limbitis 
 Endophthalmitis 
-INTRACAMERAL ROUTE: 
This procedure when performed under strict aseptic conditions ensures 
adequate drug delivery into the anterior chamber. 
-INTRASTROMAL ROUTE: 
Amphotericin B intrastromal injections have been demonstrated to be useful 
in cases of recalcitrant mycotic keratitis. 
Both intrastromal and intracameral routes are to be considered in cases with 
intraocular extension or with anterior chamber involvement. 
SUBCONJUNCTIVAL: This route is usually not preferred because of the 
toxic effects of the drugs. Miconazole is least toxic and better tolerated for 
sunconjunctival route administration. 
-USE OF STEROIDS IN FUNGAL KERATITIS: 
This is controversial as it can worsen the infection. O’Day et al: reported 
that topical steroids when given alone worsened the disease and also 
adversely affected the efficacy of antifungal agents when given in 
combination. it is therefore recommended not to consider topical steroids 
until after at least two weeks of antifungal treatment and control of infection. 
Also the steroid drop should always be used in conjunction with a topical 
antifungal agent. 
            -ROLE OF MYDRIATIC-CYCLOPLEGIC AGENT: 
a. It relieves ciliary spasm 
b. It reduces intraocular inflammation 
c. It prevents/ breaks posterior synechiae. 
SIGNS OF IMPROVEMENT IN A CASE OF FUNGAL CORNEAL 
ULCER: 
a) Reduction in size of the ulcer 
b) Rounding of the perimeters of the lesion 
c) Resolution of hypopyon  
d) Resolution of satellite lesions 
e) Reduction in intensity of stromal infiltration 
             f)Improvement in stromal and epithelial edema 
SEQUELAE OF PROGRESSIVE INFECTIOUS KERATITIS: 
• Corneal opacification 
• Iris prolapse 
• Descematocele formation- also called as keratocele. It results when the 
ulcer extends to the whole depth except for descemet’s membrane which 
cannot withstand the intraocular pressure and herniates as a transparent 
vesicle through the ulcer. 
• Corneal perforation- If perforation is small iris is gummed down to the 
opening resulting in synechiae. When whole cornea sloughs it results in 
false cornea and pseudo cornea. Corneal fistula results if perforation is 
opposite to the papillary area. 
• Adherent leukomatous opacity 
• Anterior staphyloma 
• Secondary glaucoma 
• Anterior capsular cataract 
• Lens extrusion through perforation, subluxation and dislocation of lens. 
• Hemorrhage – sudden perforation results in sudden decrease in IOP 
leading to rupture of vessels and cause vitreous hemorrhage, rupture of 
choroidal vessels leads to suprachoroidal, subretinal and expulsive 
hemorrhage. 
• Endophthalmitis & panophthalmitis 
VORICONAZOLE: It is a newer second generation triazole derived from 
fluconazole .it has broad spectrum activity against various fungi affecting the 
eye . Marangon et al: voriconazole showed high susceptibilities for aspergillus, 
candida and fusarium.32 
 Mechanism of action: 
it inhibits the enzyme cytochrome P450 dependant lanosterol 14 demethylase 
which is responsible for conversion of  lanosterol to 14_demethyl lanosterol by 
binding to the active site of the enzyme and ligating the iron heme cofactor . 
this results in accumulation of 14- methyl sterols like lanosterol and depletion 
of ergosterol which alters both function and integrity of the fungal cell 
membrane. 
It has a molecular mass of 349.32 Da that allows good corneal penetration, and 
therefore better ocular bioavailability. 
Various case reports regarding the use of topical voriconazole in fungal 
keratitis: 
1. Klont et al:reported a case of A 23-year-old man with F. solani keratitis  
who failed to respond to treatment with topical amphotericin B and 
itraconazole. The patient was then prescribed, concomitant IV and topical 
voriconazole followed by voriconazole orally and topically and this had a  
successful outcome/ 
2. Reis et al:  in this report a 16-year-old girl diagnosed with non responding 
keratitis caused by F. solani . The patient was prescribed topical 
amphotericin B and fluconazole initially , followed by itraconazole later. 
However no response was noted.A significant improvement was noticed 
upon the addition of topical voriconazole to therapy,  
3. Prats et al:  reported a 19-year-old man diagnosed as a case of S. 
apiospermum keratitis. The infection resolved eoth topical voriconazole 
4. Tu et al:  reported two cases, one a 29-year-old man who  received oral and 
topical voriconazole for  Fusarium keratitis. In the second case, a 43-year-
old woman received a combination of IV, topical, and intravitreal 
voriconazole for keratitis caused by F. solani that was associated with 
contact lens wear. In both of these cases, voriconazole was initially effective 
until it had to be discontinued because of severe hepatotoxicity. Patients 
were then switched to posaconazole as salvage therapy. 
5. Polizzi et al: reported use of 2% voriconazole eye drops in a case of ulcer 
caused by fusarium solani 
6. Jones et al: demonstrated that voriconazole was effective in a 52-year-old 
woman diagnosed as a case of Aspergillus niger keratitis who was initially 
treated with amphotericin B topically with no improvement. When the 
patient was started on a combination of oral and topical voriconazole, the 
infection resolved after five weeks / 
Intraocular penetration of systemic voriconazole:it is metabolized by liver. Its 
minimum inhibitory concentration of 0.5 microgram/ml is much less compared to 
other imidazoles.it has excellent oral bioavailability.after oral administration of 
voriconazole therapeutic  aqueous and vitreous concentrations are achieved.  
Shah et al, 2003 found the minimum inhibitory concentration of voriconazole 
was 0.5 microgram/ml a concentration lower than that of the other imidazoles. 
Hariprasad et al: oral voriconazole reaches therapeutic MIC90 concentrations in 
the vitreous and aqueous against a wide range of organisms including 
aspergillus and candida.31 
Systemic voriconazole has good intraocular penetration but it may result in 
adverse effects and also interactions with concomitant medications. Also 
systemically used it is expensive. 
Voriconazole is phototoxic, it has been noted to be associated with transient 
visual disturbances. It has been reported in around 30% of patients in various 
clinical trials though studies have shown that there is no damage to any 
structure of the eye and no long term effect on vision. 
Gao et al first demonstrated the safety of voriconazole in the eye: intravitreal 
voriconazole concentration  upto 25 mg/ml did not produce any histolological 
changes or any electroretinographic changes in the rat retina. 
Sponsel et al reported that topical voriconazole as a novel treatment for fungal 
keratitis 
Jang et al  reported that voriconazole is also effective against candida 
chorioretinitis. 
Ozbek et al reported 1 case of alternaria species keratitis that showed dramatic 
improvement to 1% voriconazole. 
Giaconi et al reported two cases caused by colletotrichum dematium and 
fusarium oxysporum which did not respond to treatment with 1% voriconazole 
eye drops. 
LITERATURE RELATED TO INTRASTROMAL INJECTION OF 
VORICONAZOLE: 
• Gaurav prakash, namrata Sharma et al did an interventional case series in 
three eyes of three patients with recalcitrant fungal keratitis non 
responding to topical antifungal medications and all three patients had 
faster reduction in size of corneal infiltration and complete resolution of 
the ulcers was noticed within three weeks after intrastromal 
administration of voriconazole.25 
• Punit K Singh, Ganesh Bhargava et al reported a series of two cases of 
deep seated fungal keratitis whose ulcer healed completely in both eyes 
after intrastromal administration of voriconazole over a period of twenty 
days. In this series only a mild improvement in visual acuity was noted 
because of the resultant scar which involved the central cornea. 
• Tu, Elmer Y MD et al described the clinical presentation of 3 cases of 
Alternaria keratitis who presented with an indolent steroid-treated 
keratitis. They also had a history of recent cataract surgery, agricultural 
trauma, or contact lens wear. None of those patients responded to 
natamycin, and 1 among them also did not respond to topical and 
systemic voriconazole.these  Patients responded rapidly to either topical 
fluconazole 0.02% or a combination of intrastromal voriconazole and 
topical caspofungin 0.5% and their final visual acuity ranged between 
20/15 and 20/25 
•
 Siatri , Heider et al observed dramatic therapeutic response in three 
patients with recalcitrant fungal keratitis as these patients failed to 
respond to 5% topical natamycin hourly and oral ketoconazole twice per 
day. One patient in this study underwent amniotic membrane 
transplantation to seal the microperforation who had chemical burn 
superinfected with fusarium.24 
•
 Namrata Sharma, prakash agarwal et al studied twelve patients with 
smear and / or culture positive fungal  keratitis who did not respond to 
both topical and systemic antifungal therapy who were given one or more 
doses of intrastromal voriconazole injection. In this study, ten patients 
healed with scar formation while two corneas perforated and required 
therapeutic penetrating keratoplasty.25 
• Vandana Jain, Nishikant Borse et al reported a case of a 50 year old 
woman who developed recalcitrant fungal tunnel infection following 
uneventful cataract surgery and found aspergillus flavus as the causative 
agent  who did not respond to intensive medical treatment. Ulcer resolved 
completely after injection of intrastromal voriconazole. 
• Namrata Sharma, Jacob Chaco et al did a randomized controlled clinical 
trial involving forty eyes of forty pstients with smear / culture proven 
fungal keratitis not responding to natamycin topically for two weeks 
comparing topical versus intrastromal voriconazole and concluded that 
intrastromal injection did not offer a beneficial effect when compared 
with topical therapy. In this study 19 patients who received topical 
voriconazole and 16 patients who received intrastromal voriconazole 
responded well to therapy.26 
• Stacy Bang , Erica Edell et al reported the  use of both topical and 
intrastromal voriconazole in three eyes with resistant acanthamoeba 
keratitis which was resistant to treatment with chlorhexidine. 
SIGNS OF NON HEALING CORNEAL ULCER: any corneal ulcer is 
considered to be a non healing one if it shows signs and symptoms of 
progression in spite of maximal therapy( based on culture and sensitivity in 
cases of infectious ulcer). Symptoms include increasing pain, redness, 
discharge, photophobia and decreasing visual acuity. Signs are as follows: 
 Increase in size of the ulcer 
 Necrotic material covering the ulcer bed with no granulation tissue 
 Increasing density of the stromal infiltrate, extending deeper than the mid 
stroma 
 No well demarcation of the ulcer with increasing corneal haze and 
stromal edema. 
 Increasing hypopyon and increasing anterior chamber reaction 
 Absence of peripheral corneal vascularisation. 
CAUSES OF NON HEALING CORNEAL ULCER:it can be classified as 
both local and systemic causes. Local causes include : 
• eyelid and eyelash abnormalities like ectropion, entropion, trichiasis, 
lagophthalmos, blepharitis, meibomitis which does not allow the ulcer by 
either mechanical irritation, exposure, tear film instability and 
contributing infection. 
• Infections of the lacrimal sac both acute and chronic dacryocystitis 
• Conjunctival surface disorders like stevens Johnson syndrome, foreign 
body in the tarsal conjunctiva, conjunctival concretions. 
• Causes of dry eye like primary keratoconjunctivitis sicca and sjogren’s 
syndrome as tear film forms an important defense mechanism by 
mechanical washing out the infecting agent, anti bacterial action of tear 
film constituents and by supplying oxygen to the cornea. 
• Neurotrophic keratitis as decreased corneal ulceration leads to loss of 
epithelial integrity and thereby leading on to epithelial and stromal 
ulceration. 
• Secondary glaucoma as increased intraocular pressure affects the corneal 
nutrition by causing impairment of diffusion of fluid through the cornea. 
Systemic causes include diabetes mellitus causing delayed epithelial healing, 
malnutrition, immunosuppression, chronic alcoholism. Common causes of 
non healing ulcer include poor compliance of the patient, inappropriate 
antimicrobials and no proper microbiological work up being done. 

 
PROGNOSIS OF FUNGAL KERATITIS : It varies depending on the depth and 
size of the lesion and the causative organism. small superficial infections respond 
well to topical therapy generally. Deep stromal infections and with concomitant 
scleral or intraocular involvement are much more difficult to eradicate. 
 One prospective, interventional study involving 115  cases with fungal keratitis 
assessed treatment outcomes and prognosis after 1 month of topical natamycin 
use.] 52 were considered treatment successes, 27 patients had slow-healing ulcers, 
and 36 were reported as treatment failures. Multivariate analysis highlighted that 
the three factors associated with treatment failure were large ulcer size (greater 
than 14 mm2), the presence of a hypopyon, and Aspergillus as the causative 
organism. Surgical therapy can prove successful when medical treatment fails or 
can be tried as a secondary measure for visual rehabilitation. 
  
 
ROLE OF SURGERY IN FUNGAL KERATITIS: 
At present surgery is seldom needed during the acute phase of the infection 
although it may be required later to restore vision if significant corneal scarring 
occurs.  About one third of fungal infections require surgical intervention as a 
result of treatment failures or perforation.forst Surgical management can be 
employed in one of the following forms: 
i. Tissue adhesives: cyanoacrylate glue is used for perforation less than 1 
mm or in cases of descematocele 
ii. Debridement:it aids in reducing the microbiological and antigenic load. It 
is the simplest type of surgical intervention and can be performed under 
slit lamp under topical anaesthesia.It also facilitates drug penetration, 
provides material for culture and prevents early epithelisation over areas 
of stromal infiltrarion. 
iii. Cauterization: it can be done by either thermal or chemical methods. The 
chemicals involved in cautery include 20% trichloroacetic acid or 100% 
carbolic acid or iodine.it destroys the organism but leaves behind a 
permanent opacity thereby not used in central ulcers. It is contraindicated 
in thinned out corneas and perforated ulcers. 
iv. Conjunctival flap: it is coupled with debridement in cases of non healing 
ulcers. It serves as a structural support and provides increased antibodies 
by increasing blood supply. 
v. Superficial keratectomy aids in removing the devitalized tissues and 
fungal elements. 
vi. Tectonic graft 
vii. Penetrating keratoplasty: it is the ideal procedure in cases of progressive 
non healing ulcers. The main aim here is to control the infection and 
maintain the structural integrity.Note that the trephination should extend 
1-2 mm beyond the infiltrate.the indications of penetrating keratoplasty 
in keratomycosis are:  
• Progressive ulceration 
• Perforated cornea 
• Impending perforation 
• Extensive drug toxicity 
• Uncontrolled inflammation 
Following penetrating keratoplasty topical antifungals should be used to prevent 
recurrence. 
  
COMPLICATIONS OF KERATOPLASTY: 
• Intraoperative complications include: sclera perforation, trephination related 
problems, retained descemets membrane, endothelial damage, vitreous loss, 
intraocular hemorrhage 
• Early Post operative complications include wound leak, papillary block, 
postoperative inflammation, raised intraocular hemorrhage, suture related 
infiltrates and vascularisation 
• Late post operative complications include astigmatism, graft infection, graft 
rejection and glaucoma. 
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PART-2 
  
 
 
AIM OF THE STUDY: 
1. To evaluate the role of intrastromal voriconazole in fungal corneal ulcers 
refractory to topical antifungals. 
2. To identify the fungal species causing keratitis 
3. To determine the fungal species most responsive to voriconazole. 
4. To determine the nature of injurious agents in causing keratitis. 
 
 
 
 
 
 
 
 
 
 
  
MATERIALS AND METHODS: 
The study was conducted in Regional Institute of Ophthalmology. Patients with 
corneal ulcer were followed for a period of one year.464 cases of corneal ulcer 
were treated in our hospital. Out of the fungal culture positive cases 25 cases were 
selected for the study who did not respond to topical antifungals for more than one 
week and in whom other causes of non healing corneal ulcer(systemic causes like 
uncontrolled diabetes, immunosuppressed state and local causes like entropion, 
ectropion, trichiasis, lagophthalmos, lacrimal sac infections, ocular surface 
disorders) were ruled out. These patients were treated with 50 microgram/0.1 ml of 
intrastromal voriconazole injection.  
INCLUSION CRITERIA: 
 Patients in age group of ten years and above of either sex. 
 Patients presenting with corneal ulcers of proven fungal etiology by KOH 
mount and who did not show why improvement on topical antifungals after 
one week. 
EXCLUSION CRITERIA: 
 Patients aged less than ten years. 
 Patients with impending perforation/ perforated corneal ulcers. 
 Patients presenting with associated bacterial corneal ulcers/ peripheral 
ulcerative keratitis. 
 Patients presenting with healing corneal ulcers. 
 Pregnant females 
 Patients with uncontrolled diabetes mellitus, other systemic diseases and 
immunocompromised state. 
 Patients presenting with corneal ulcers with involvement of adjacent sclera 
and concomitant endophthalmitis. 
 
 
 
 
 
 
 
 
 
 COURSE OF THE STUDY: 
 Patients presenting with corneal ulcer were subjected to detailed 
ophthalmological examination including visual acuity, slit lamp 
biomicroscopy- the findings to be noted in slit lamp include: the area and 
density of infiltration, size and depth of ulceration, size of epithelial defect, 
degree of stromal edema, anterior chamber reaction and sclera 
involvement,syringing of the nasolacrimal duct, routine smear studies under 
sterile conditions on precleaned glass slides-one for 10% KOH mount to 
look for fungal elements and another slide for Gram stain to look for 
bacterial pathogens. Additionally, the corneal scraping was inoculated in 
Sabouraud’s agar and kept at room temperature too. Random blood sugar 
and urine sugar testing too was done to rule out diabetes mellitus. 
 The fungal species were confirmed by growth in culture media. Species 
identification was done with lactophenol cotton blue for 25 culture positive 
cases. 
 Sociodemographic data of these patients and the information related to risk 
factors too was noted like history of any trauma. 
 Those patients aged more than ten years in whom initial smear studies and 
clinical features favour fungi as the causative agent were treated with 5% 
natamycin , fluoroqinolone antibiotics to prevent superadded bacterial 
infection and adjuvant medications such as atropine eye drops. those patients 
in whom signs and symptoms of progression were noted despite one week of 
topical medication and in whom both local and systemic causes of non 
healing ulcer were ruled out were treated with 50 microgram/0.1 ml of 
intrastromal injection of voriconazole. 
 Informed consent was obtained from the patients before administration of 
the drug 
 Method of intrastromal administration: 1 mg of voriconazole  containing vial 
was reconstituted with 2 ml of distilled water. The reconstituted solution was 
loaded in syringe with 26 gauge bent needle.Under total aseptic 
precautions,under topical anaesthesia, 0.1 ml of the preloaded drug was 
administered under the operating microscope.The needle was inserted 
obliquely from clear area to the ulcer at mid stromal level.Multiple injections  
were given circumferentially to ensure formation of drug depot around the 
entire lesion. 
  Poststromal injection all patients were continued on topical antifungals.  
 Patients were examined every day under the slit lamp and response to 
therapy documented recording the size of the ulcer and the best corrected 
visual acuity 
 All these patients were followed up for a period of 30 days. 
 When  patients did not show any improvement and had gross structural 
damage or developed perforation or signs of impending perforation were 
taken up for urgent therapeutic keratoplasty.  
 
ASSESMENT OF PARAMETERS: the following parameters are 
assessed- visual acuity, size of the infiltration , hypopyon and associated 
features .  
1. Symptomatic improvement in the patient 
2. Decrease in epithelial defect and infiltration 
3. Improvement in patient’s best corrected visual acuity 
4. Resolution of hypopyon if present 
 
 
 
 
 
 
ANALYSIS: 
1.AGE DISTRIBUTION: 
Table 1: age wise distribution 
AGE NUMBER PERCENTAGE 
10-19 1 4% 
20-29 3 12% 
30-39 5 20% 
40-49 8 32% 
50-59 6 24% 
60-69 2 8% 
Chart 1- agewise distribution 
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 SEX DISTRIBUTION: 
 
TABLE 2: SEX DISTRIBUTION 
 
S.NO SEX NUMBER PERCENTAGE 
1 MALE 17 68% 
2 FEMALE 8 32% 
 
CHART 2: SEX DISTRIBUTION 
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OCCUPATION: 
Table 3: occupation wise distribution 
S.NO OCCUPATION NUMBER PERCENTAGE 
1 farmer 11 44% 
2 Housewife 4 16% 
3 Labourer 6 24% 
4 Others 4 16% 
 
Chart 3: occupation wise distribution 
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TABLE 4: EYE LATERALITY 
S.NO EYE NUMBER PERCENTAGE 
1 RIGHT EYE 12 48% 
2 LEFT EYE 13 52% 
 

CHART 4: EYE LATERALITY 
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TABLE 5: injuring agent 
S.NO NATURE OF INJURING AGENT NUMBER PERCENTAGE 
1 Vegetable matter 8 32% 
2 Wooden stick 6 24% 
3 Thorn 1 4% 
4 Foreign body including mud particle, cement 3 24% 
5 Others/ no injuring agent 4 16% 
 
 
Chart 5: injuring agent 
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FUNGAL SPECIES ISOLATED ON CULTURE: 
Table 7 : fungal species isolated on culture 
S.NO FUNGAL SPECIES NUMBER PERCENTAGE 
1 Aspergillus niger 6 24% 
2 Aspergillus fumigates 8 32% 
3 Aspergillus flavus 4 16% 
4 Fusarium 6 24% 
5 Zygomycetes 1 4% 
 
Chart 7: fungal species isolated on culture 
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SIZE OF THE ULCER 
CHART 8: SIZE OF THE ULCER PRE AND POST TREATMENT 
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The healing ratio is taken for one patient at a time. 
The x-axis values represent the patient numbers. 
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 VISUAL ACUITY: 
TABLE: 9: VISUAL ACUITY PRE TREATMENT 
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TABLE 10: VISUAL ACUITY POST TREATMENT 
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CHART 12: RESPONSE OF DIFFERENT FUNGAL SPECIES TO 
INTRASTROMAL VORICONAZOLE: 
 
S.NO SPECIES NUMBER OF PATIENTS WHO 
RESPONDED WELL 
PERCENTAGE 
1 Asp. 
Fumigates 
 6 out of 8 75% 
2 Asp. Niger 4 out of 6 66.66% 
3 Asp. Flavus 1 out of 4 25% 
4 Fusarium 5 out of 6 83.33% 
5 Zygomycetes 1 out of 1 100% 
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CHART 14: 
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RESPONSE: 
 
S.NO RESPONSE NUMBER PERCENTAGE 
1 HEALED 17 68% 
2 TAKEN FOR TKP 8 32% 
 
 
CHART 15: RESPONSE TO INTRASTROMAL VORICONAZOLE 
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Among 25 patients 8 were taken for therapeutic keratoplasty as they developed 
signs of impending perforation/ perforated. 
ADVERSE EFFECTS: 
None of the patient developed any side effect to intrastromal injection of 
voriconazole.  
 
 
 
 
 
 
 
 
 
  
DISCUSSION: 
Treating a case of fungal keratitis is a challenge for the ophthalmologist as the 
penetration of many antifungal agents commonly used remains inadequate. In this 
study we have reported the use of voriconazole in twenty five patients who did not 
show any improvement to topical antifungal agents even after one week of 
treatment.  
Voriconazole is a broad spectrum antifungal agent though systemic administration 
has good intraocular penetration it is very costly. Therefore an economical and 
efficient strategy of using voriconazole in the management of fungal keratitis is 
needed which can be achieved by intrastromal route which we have employed in 
this study. 
In our study 52% of cases belonged to male sex. This slight preponderance could 
be due to males being more involved in outdoor activities and therefore prone for 
injury.This has been pointed out by Whitcher in an article named “prevention of 
corneal ulcer”. Also this is in accordance to several studies reported earlier like the 
Madurai study by Srinivasan et al which had male: female ratio as 1.6:1. Here in 
our study the ratio was 1.08.37 
 With respect to age distribution 32 %  of cases fall in the age group 40-49 years . 
this is in conformity with studies like done by Laspina et al40 where  it was noted 
that the greatest incidence was in the age group of 30-59 years As per review of 
1352 patients in south india by Gopinathan, Usher et al males are significantly 
affected more with 64.4% of cases in the younger age group (16-49 years) . 
Majority of cases belonged to lower socioeconomic group with farmers being 
predominantly involved ( 44% of cases in our study) like the one done by Rahman 
et al. 
History of injury was present in 84 % of cases with vegetable matter injury being 
the common inciting agent. Trauma was the major causative agent in fungal 
corneal ulcers as per study by Upadhyay MP, Karmacharya PC et al39. vegetable 
matter injury has been reported in many studies before like the one conducted by 
Bharathi et al . 
Fungal keratitis has a varied clinical presentation. Hypopyon was present in 76% 
of cases, satellite lesions in 16% and immune ring was seen in  8% of patients.A 
three-year study by C#-##, &<"#, 
,"! et al8at Aravind 
Eye Care System, TirunelveliD Tamil Nadu,  reported that  the clinical picture of 
fungal keratitis is pleomorphic. It varies from individual to individual, and largely 
depends on the type of  causative fungus, invading pathogen’s severity, liberation 
of toxins, age of the patient and resistance of the host tissue/The unique features 
noted were a dry, raised lesion with a feathery or hyphate border and/ or as stromal 
infiltration. Satellite lesions were seen in 10% patients in that study. Other lesions 
that helped in diagnosis were cheesy hypopyon in 55.6% patients, immune ring in 
1.37% patients, corneal perforation in 1.37% and posterior corneal abscess in 1% 
of the patients studied. The sensitivity and specificity of clinical diagnosis of 
fungal keratitis was 94.1% and 94.58% respectively made by an ophthalmologist 
using slitlamp biomicroscope  
In our study Among the species identified, the most common species were 
aspergillus fumigatus. This was similar to the study results by Chowdhary, 
Anuradha Singh, Kirt et al where The spectrum of fungi isolated were Aspergillus 
species in 78 (41%) followed by Curvularia species in 55 (29%).As per study by 
Vajpayee et al  fusarium was reported to be the most frequent cause of fungal 
keratitis, causing up to 32% of these infections. 
Size and depth of the ulcer have a role in determining the outcome to treatment as 
superficial and smaller ulcers responded well to the treatment compared to those 
which were larger and involving the inner thirds of stroma. 
In our study 60% of the total cases presented with visual acuity of less than 1/60. 
Following treatment with intrastromal voriconazole 48% of cases had visual acuity 
of less than 1/60.  
Five out of six fusarium patients responded well with voriconazole injection given 
intrastromally. 
 Of  twenty five cases studied here, 68% had good response which was 
documented by decrease in ulcer size and improvement in visual acuity and 32% 
were taken for therapeutic keratoplasty. 
 
 
 
 
 
 
 
 
 
 SUMMARY: 
 Majority of the patients were males. 
 Common age group affected 40-49 years 
 Most common injuring agent was found to be vegetable matter( 32% of 
cases) followed by wooden stick 
 Occupation- farmers were commonly involved 
 The most common organism isolated among 25 culture positive cases were 
aspergillus fumigates 
 Hypopyon was present in 76% of patients indicating the severity of ulcers at 
presentation . 
 Most of the patients fall into grade two and three severity as 68% of patients 
presented with ulcers greater than 4 mm area. 
 The species which had shown better  response to intrastromal voriconazole 
was fusarium and zygomycetes. 
 17 cases responded well to intrastromal voriconazole injection. 
  8 cases did not respond to treatment and underwent therapeutic 
keratoplasty. 
 None of the patients developed any side effects to the voriconazole drug 
given intrastromally. 
 Decrease in ulcer size and improvement in visual acuity was noted in 
responded cases. The improvement in visual acuity is not very significant 
here as the ulcer heals to form a scar obscuring the visual axis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 CONCLUSION: 
 Modalities of targeted delivery like intrastromal injections can 
improve the clinical outcomes of deep seated fungal corneal ulcers 
unresponsive to topical antifungals.  
 Intrastromal administration of voriconazole might be a safe and cost-
effective method of providing higher concentration of the drug. 
 It also helps in delaying the progression of ulcer when the patient is 
waiting for donor cornea for TKP.  
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NAME      :                                                                     OCCUPATION    :                                              
CCNO       :            
AGE          :                                                                     OPNO/IPNO        :  
SEX          :                                                                     DOA                     :  
 
C/O PAIN/IRRITATION/REDNESS/WATERING                                          
DURATION: 
EYE: 
H/O TRAUMA:                     
 
PAST H/O:DM/HT/TB/ASTHMA/ORGAN TRANSPLANTATION/HIV 
H/O CONTACT LENS USE                
H/O DRUG INTAKE                            
PERSONAL H/O:H/O SMOKING     
OCCUPATIONAL HISTORY: 
GENERAL EXAMINATION 
EXAMINATION OF THE EYES                           RE                               LE            
 
VISION 
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OCULAR MOVEMENTS  
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 CORNEA – SIZE OF ULCER 
                     DEPTH 
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                                      INVESTIGATIONS   
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TENSION                                                                                                                                          
FUNDUS                                                                                                                                           
 RBS                                                                                                                                                        
URINE ALB   /SUGAR      
CORNEAL SMEAR: 
 KOH MOUNT 
 GRAM STAIN 
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INTRASTROMAL VORICONAZOLE GIVEN ON: 
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KEY TO MASTER CHART 
RE- RIGHT EYE 
LE- LEFT EYE 
TKP- THERAPEUTIC PENETRATING KERATOPLASTY 
ASP - ASPERGILLUS SPECIES 
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